uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Pharmacist perceptions and assignment of medication related risks- implications for practice
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
2015 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Introduction: Pharmacists play a critical role in the provision of information to ensure safe and effective use of medication(s) by the patient. Certain therapeutic classes are known to impair alertness (e.g. hypnotics and antiemetics) which poses important safety concerns for the patient when undertaking activities which require high levels of psychomotor vigilance (e.g. driving or operating machinery). Although standard practice protocols exist to guide pharmacists’ communication (i.e. L1/ L1a labels used in Australia) with the patient, little is known about the effectiveness of standard protocols or how pharmacists perceive and/or assign medication-related risks. Aim: To explore pharmacists current perceptions and communication of medication-related risks in routine clinical practice and to determine the feasibility of implementing new clinical resources in practice. Methods: In-depth semi-structured interviews were conducted with six community pharmacists across Australia. Interviews were digitally recorded and transcribed verbatim before analysis to identify emergent themes.  A brief survey was also administered to collect demographic information and validated measures of risk perception. Results: The current provision of information about medication-related risks appears to be dictated by patients’ prior experiences. Many expressed a desire to extend their therapeutic knowledge in this area and welcomed the idea of a new labeling system but highlighted that inter-patient variability could pose challenges for assigning precise levels of risk or the duration of effect. Conclusions: Communication of medicine-related risk is influenced by patients’ beliefs and interests about medications as well as pharmacists’ clinical experience. Extending pharmacists’ clinical knowledge in this therapeutic area and refining clinical resources represents key steps towards optimizing risk communication in practice. 

Place, publisher, year, edition, pages
2015. , 32 p.
Keyword [en]
Driving impairing medicines, DRUID- project, Pictograms, Risk communication, Warning labels
National Category
Social and Clinical Pharmacy
URN: urn:nbn:se:uu:diva-258504OAI: oai:DiVA.org:uu-258504DiVA: diva2:841804
Subject / course
Pharmaceutical Biosciences
Educational program
Master of Science Programme in Pharmacy
Available from: 2015-08-17 Created: 2015-07-14 Last updated: 2015-08-17Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Pharmaceutical Biosciences
Social and Clinical Pharmacy

Search outside of DiVA

GoogleGoogle Scholar

Total: 211 hits
ReferencesLink to record
Permanent link

Direct link